The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes.

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

In the ongoing fight against obesity, a growing epidemic with grave medical consequences, a new class of weight loss medications offers unprecedented hope. Drugs like semaglutide (Wegovy ...

By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...